Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 19/20 | 0.42 |
| ▸ | HTR2A | P28223 | 19/20 | 0.42 |
| ▸ | HTR2C | P28335 | 19/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5637105 | 0.98 | DRD2 (0.42) | DRD2HTR2AHTR2CKDM4EALDH1A1 | |
| SCHEMBL5637094 | 0.95 | DRD2 (0.42) | DRD2HTR2AHTR2CKDM4EALDH1A1 | |
| SCHEMBL5638143 | 0.90 | HTR2C (0.44) | DRD2HTR2AHTR2C | |
| SCHEMBL5636889 | 0.88 | HTR2C (0.40) | DRD2HTR2AHTR2C | |
| SCHEMBL5635026 | 0.84 | HTR2C (0.44) | DRD2HTR2AHTR2CALDH1A1 | |
| SCHEMBL5636365 | 0.82 | HTR2C (0.38) | DRD2HTR2AHTR2C | |
| SCHEMBL5638305 | 0.81 | DRD2 (0.38) | DRD2HTR2AHTR2C | |
| SCHEMBL5636086 | 0.81 | USP30 (0.45) | DRD2HTR2AHTR2C | |
| SCHEMBL5637203 | 0.79 | HTR2A (0.45) | DRD2HTR2AHTR2C | |
| SCHEMBL5636300 | 0.79 | HTR2C (0.50) | DRD2HTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE39679-E1 | Substituted heterocycle fused gamma-carbolines | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2007-06-05 | — | — | US | disclosed |
| US-6713471-B1 | SUCH AS TERT-BUTYL-1-METHYL-6,7,9,12-TETRAHYDRO-5H-PYRIDO-(4,3-B)(1,4) THIAZEPINO(2,3,4-HI)INDOLE-11(10H)-CARBOXYLATE; SEROTONIN AGONISTS AND ANTAGONISTS; CENTRAL NERVOUS SYSTEM DISORDERS | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2004-03-30 | — | — | US | disclosed |